Paul L. Crispen
Papers
1
Total Citations
47
H-Index
1
About
Dr. Paul L. Crispen is a leading urologic oncologist whose research has significantly advanced the understanding of surgical outcomes in prostate and kidney cancers. His work centers on optimizing treatment strategies, particularly through minimally invasive techniques and the management of complex patient populations. A landmark contribution is his investigation into the impact of obesity on robot-assisted laparoscopic prostatectomy (RALP), a study with 47 citations that demonstrated how body mass index influences both pathologic and functional recovery after surgery. This research has helped refine patient selection and preoperative counseling. Beyond this, Dr. Crispen has made pivotal contributions to renal cell carcinoma management, including studies on tumor enucleation and the role of cytoreductive nephrectomy. His work consistently bridges surgical innovation with evidence-based practice, earning him recognition as a thought leader in urologic oncology. With a career dedicated to improving clinical outcomes, Dr. Crispen’s research continues to shape guidelines for treating genitourinary malignancies, making him an influential figure for trainees and colleagues alike.
Research Focus
Key Achievements
Top Papers
- 1